Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 26, 2025

Primary Completion Date

April 15, 2026

Study Completion Date

April 15, 2026

Conditions

FatigueInflammation

Interventions

DRUG

Fucoidan extracted from F. Vesiculosus

4 g daily

DRUG

Fucoidan extracted from U. Pinnatifida

4 g daily

Trial Locations (1)

RECRUITING

University of Rochester Medical Center, Rochester

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Rochester

OTHER

NCT06295588 - Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer | Biotech Hunter | Biotech Hunter